KEISHA SMITH: Open Payments
NPI 1831510007 · RALEIGH, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$417 in 16 payments from 9 companies in 2025. Trend: 2023 $49 · 2024 $183 · 2025 $417
Food & beverage: $417
| Company | Payments | Amount |
|---|---|---|
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 1 | $101 |
| Novartis Pharmaceuticals Corporation | 4 | $77 |
| Novo Nordisk Inc | 2 | $47 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $47 |
| Amgen Inc. | 2 | $41 |
| E.R. Squibb & Sons, L.L.C. | 2 | $40 |
| Kestra Medical Technology Services, Inc. | 1 | $24 |
| Alnylam Pharmaceuticals Inc. | 1 | $20 |
| PFIZER INC. | 1 | $19 |
Products named: LifeVest, LEQVIO, Wegovy, JARDIANCE, REPATHA, CAMZYOS, Assure WCD, AMVUTTRA.
Industry payments across NC — which companies pay providers there.
